Showing results (1761-1770 of 1,800) with videos related to
Sort By:
Pageof 180
Annals of the Rheumatic Diseases|April 11, 2009
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusJ G Hanly, M B Urowitz, L Su, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 12, 2021
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) RegistryZobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, et al.JAMA|December 9, 2024
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical TrialPaul Dark, Anower Hossain, Daniel F McAuley, et al.Journal of Fish Biology|March 15, 2018
Fishes in a changing world: learning from the past to promote sustainability of fish populationsT A C Gordon, H R Harding, F K Clever, et al.The New England Journal of Medicine|June 1, 2017
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV InfectionMarc Bourlière, Stuart C Gordon, Steven L Flamm, et al.Critical Care Medicine|February 16, 2021
Sepsis Subclasses: A Framework for Development and InterpretationKimberley M DeMerle, Derek C Angus, J Kenneth Baillie, et al.Arthritis Care & Research|April 8, 2017
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper PatientsD Isenberg, J Sturgess, E Allen, et al.American Journal of Respiratory and Critical Care Medicine|April 30, 2024
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICUAnthony C Gordon, Narges Alipanah-Lechner, Lieuwe D Bos, et al.The Lancet. Gastroenterology & Hepatology|August 19, 2017
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept studyDavid Jones, Pol F Boudes, Mark G Swain, et al.Lupus Science & Medicine|April 22, 2016
Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohortM B Urowitz, D D Gladman, N M Anderson, et al.Pageof 180